Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹45 Cr
P/E Ratio
29.58
P/B Ratio
1.64
Industry P/E
40.64
Debt to Equity
0.59
ROE
5.73 %
ROCE
8.22 %
Div. Yield
0 %
Book Value
36.67
EPS
2.03
CFO
₹13.61 Cr
EBITDA
₹26.36 Cr
Net Profit
₹6.90 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Chandra Pharma
| -8.63 | -4.15 | -11.76 | -41.19 | -20.35 | 14.01 | -- |
|
BSE Healthcare*
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Small Cap#
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Chandra Pharma
| -40.44 | 3.57 | 25.56 | 100.00 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 735.15 | 6,661.19 | 26.72 | 13.8 | |
| 530.60 | 8,351.33 | -- | 0.11 | |
| 1,069.80 | 8,742.78 | 72.03 | 12.96 | |
| 452.55 | 10,967.83 | 22.89 | 14.4 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2003
Chairman
Hemant Chandravadan Bhagat
Managing Director
Hemant Chandravadan Bhagat
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Chandra Bhagat Pharma Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Chandra Bhagat Pharma Ltd stood at ₹ 102 Cr as on 31-Mar-24
The share price of Chandra Bhagat Pharma Ltd is ₹60.00 (BSE) as of 17-Apr-2025 IST. Chandra Bhagat Pharma Ltd has given a return of -20.35% in the last 3 years.
Chandra Bhagat Pharma Ltd has a market capitalisation of ₹ 45 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Chandra Bhagat Pharma Ltd is 1.64 times as on 17-Apr-2025, a 54% discount to its peers’ median range of 3.57 times.
The P/E ratio of Chandra Bhagat Pharma Ltd is 29.58 times as on 17-Apr-2025, a 27% discount to its peers’ median range of 40.64 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Chandra Bhagat Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Chandra Bhagat Pharma Ltd.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
The prominent promoters of Chandra Bhagat Pharma Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Hemant Chandravadan Bhagat |
35.5%
|
|
Chitra Hemant Bhagat |
16.34%
|
|
Pranav Hemant Bhagat |
10.1%
|
|
Prachi Pranav Bhagat |
3.53%
|
The chairman of the company is Hemant Chandravadan Bhagat, and the managing director is Hemant Chandravadan Bhagat.
There is no promoter pledging in Chandra Bhagat Pharma Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,968
|
|
|
8,743
|
|
|
8,351
|
|
|
6,661
|
| Chandra Bhagat Pharma Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
5.73
|
|
Operating margin(%)
|
-3.47
|
|
Net Margin(%)
|
0.66
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Chandra Bhagat Pharma Ltd was ₹2 Cr.
₹5.00
(
